Found 13 matching trials
Extended Pelvic Lymph Node Dissection vs. no Pelvic Lymph Node Dissection at Radical Prostatectomy for intermediate-and High-risk Prostate Cancer PHASE3 For patients with intermediate-risk prostate cancer plus a predicted risk o...
Show More Location
Kantonsspital Aarau AG
Learn More & Join Trial
Ferumoxtran-10-enhanced MRI in Prostate Cancer Patients PHASE3 This will be a confirmatory, prospective, open-label, single-arm, reader-bl...
Show More Location
Universitair Ziekenhuis Ghent
Learn More & Join Trial
Preoperative PSMA PET/CT As Triage for EPLND in Patients Scheduled for RALP (PrePSMA) NA Extended pelvic lymph node dissection (ePLND) is considered the gold standa...
Show More Location
Oslo University Hospital
Learn More & Join Trial
A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to Histopathology PHASE2 This was a multicenter, multi-reader, open-label, Phase 2 study assessing t...
Show More Location
City of Hope National Cancer Center
Learn More & Join Trial
The Prognostic Role of Lymph Node Dissection In Men With Prostate Cancer Treated With Radical Prostatectomy NA An extended pelvic lymph node dissection (ePLND) is the most accurate stagi...
Show More Learn More & Join Trial
Darolutamide+ADT Post-RP w/o ePLND in hrPC: Briganti 2019 PHASE2 The goal of this clinical trial is to evaluate whether adjuvant darolutamid...
Show More Location
Peking University First Hospital
Learn More & Join Trial
Dutch National Randomized Study: PSMA-PET/CT As a Triage Tool for Pelvic Lymph Node Dissection in Prostatectomy Patients NA To determine if the use of Prostate-Specific Membrane Antigen Positron Emis...
Show More Location
Canisius Wilhelmina Ziekenhuis
Learn More & Join Trial
Ga-68-PSMA-11 in High-risk Prostate Cancer PHASE1 This will be an open-label, single-arm, rater-blinded, multicenter, diagnos...
Show More Location
Medizinische UniversitÀt Innsbruck
Learn More & Join Trial
Rezvilutamide With Radical Prostatectomy and Metastasis-Directed Therapy in Oligometastatic Prostate Cancer PHASE2 Prostate cancer represents the second most common malignancy in men worldwi...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Efficacy and Safety of Radical Prostatectomy (RP) With or Without Salvage Radiotherapy Versus RP With Extended Pelvic Lymph Node Dissection for Localized Intermediate- and High-risk Prostate Cancer With a Briganti Nomogramâ„7% NA The goal of this clinical trial is to evaluate efficacy and safety of radic...
Show More Learn More & Join Trial